Hypocalcaemia after intravenous bisphosphonate: adjuvant bisphosphonate is not currently accepted practice.
Palmieri
Carlo
C
Dhillon
Tony
T
Coombes
Charles
C
Vigushin
David
D
D000963:Antimetabolites / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D017024:Chemotherapy, Adjuvant; D004002:Clodronic Acid / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D007262:Infusions, Intravenous
D000963:Antimetabolites; D004164:Diphosphonates; D004002:Clodronic Acid